MIRNA THERAPEUTICS INC Chart calendar Mirna Therapeutics Inc
1f544901bfc3700dc6d45de3d.OBM803ovzpAAU0LPkuGSP7f8HhivLK3yurqLucyBU-I.bj5p5SVJqOh2CRugpIv7RtKZRF72FOq79Ijy0pr4NoVsenrmLnih3XYcDw~6e4568ef9f717bda2febbbc88cdd81c4
Upcoming events on Mirna Therapeutics Inc
Past events on Mirna Therapeutics Inc
| 14/05/2024 04:30 pm | Q1 2024 Earnings Release |
| 19/03/2024 04:30 pm | Q4 2023 Earnings Release |
| 17/01/2024 08:30 pm | Sidoti & Company LLC Micro Cap Virtual Conference |
| 10/12/2023 01:05 am | Microbiome Engineering International Conference - Poster Session B |
| 16/11/2023 08:30 pm | Sidoti Microcap Virtual Conference |
| 09/11/2023 05:30 pm | Q3 2023 Earnings Release |
| 03/10/2023 02:00 am | Chardan Genetic Medicines Conference - Fireside Chat |
| 21/09/2023 06:30 pm | Extraordinary Shareholders Meeting |
| 13/09/2023 07:00 pm | H.C. Wainwright Global Investment Conference |
| 10/08/2023 04:30 pm | Q2 2023 Earnings Release |
| 11/07/2023 | SVB Securities Therapeutics Forum |
| 15/06/2023 05:30 pm | Annual General Meeting |
| 07/06/2023 11:30 pm | Jefferies Global Healthcare Conference |
| 02/06/2023 04:15 am | Synthetic Biology Engineering Evolution & Design Conference |
| 02/06/2023 | Synthetic Biology Engineering Evolution & Design Conference - Poster Number - 51C |
| 01/06/2023 | Synthetic Biology Engineering Evolution & Design Conference - Poster Number - 51B |
| 31/05/2023 04:30 am | Synthetic Biology Engineering Evolution & Design Conference - Poster Number - 38A |
| 11/05/2023 04:20 pm | Q1 2023 Earnings Release |
| 11/05/2023 12:00 am | Sidoti Micro-Cap Virtual Conference |
| 29/03/2023 04:10 pm | Q4 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2,22 1,34 65.83% | 0,55 0,53 2.83% | 1,75 1,36 28.52% | 1,18 1,31 -10.06% | 3,37 3,34 1.06% | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -54,4 -56,1 2.95% | -60,5 -60,5 0.08% | -60,8 -63,0 3.49% | -67,4 -68,2 1.14% | -55,2 -58,1 5.08% | 0,00 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -51,4 -53,5 3.96% | -59,2 -59,2 0.11% | -60,6 -62,8 3.62% | -66,1 -67,5 1.99% | -57,3 -55,8 -2.67% | 0,00 |
|
Net income Million USD | Released Forecast Spread | -51,4 -53,5 3.96% | -59,2 -59,1 -0.12% | -60,6 -62,8 3.53% | -66,1 -67,7 2.24% | -57,3 -54,1 -5.79% | -22,2 |
|
EPS USD | Released Forecast Spread | -25,5 -26,8 4.95% | -24,7 -25,1 1.39% | -16,3 -17,5 6.36% | -13,8 -14,1 1.87% | -8,81 -6,25 -40.88% | -1,91 |
| Announcement Date | 12/03/20 | 25/03/21 | 17/03/22 | 29/03/23 | 19/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,24 0,16 52.5% | 0,15 0,12 26.67% | 0,68 0,09 674.86% | 0,11 0,23 -52.89% | 0,17 0,14 24.51% | 0,04 0,13 -72.29% | 0,39 0,08 399.56% | 2,77 2,74 1.24% | 0,01 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -15,8 -17,5 9.8% | -16,0 -16,6 3.46% | -18,3 -16,1 -13.77% | -17,3 -18,1 4.32% | -16,2 -17,2 5.54% | -15,7 -20,4 23.34% | -12,6 -22,5 43.81% | -10,6 -13,6 21.73% | ||||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -15,7 -17,4 9.9% | -15,8 -16,6 4.37% | -17,9 -16,1 -11.22% | -16,7 -18,1 7.63% | -15,6 -16,9 7.75% | -15,0 -19,9 24.42% | -12,1 -21,9 44.89% | -14,5 -13,0 -11.43% | ||||
|
Net income Million USD | Released Forecast Spread | -15,7 -17,0 7.75% | -15,8 -16,4 3.66% | -17,9 -16,1 -11% | -16,7 -18,2 8.51% | -15,6 -17,0 7.87% | -15,0 -17,9 16.16% | -12,1 -18,6 35.08% | -14,5 -11,4 -27.26% | -31,6 -9,30 -239.4% | -6,20 | -4,20 | -2,50 |
|
EPS USD | Released Forecast Spread | -3,30 -4,20 21.43% | -3,30 -3,49 5.38% | -3,75 -3,49 -7.53% | -3,60 -3,83 5.88% | -3,45 -3,49 1.08% | -3,15 -3,55 11.27% | -2,57 -2,56 -0.59% | -0,97 | -2,60 -0,80 -225% | -0,54 | -0,36 | -0,21 |
| Announcement Date | 12/05/22 | 11/08/22 | 10/11/22 | 29/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 19/03/24 | 14/05/24 | - | - | - |
| 21/05/2024 | ALVOTECH: Q1 2024 Earnings Release |
| 21/05/2024 04:30 pm | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 22/05/2024 | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
| 22/05/2024 | EVOTEC SE: Q1 2024 Earnings Release |
| 01/07/2024 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
| 15/07/2024 11:15 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 22/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 24/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Mirna Therapeutics Inc
| 17/05/2024 11:30 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 16/05/2024 01:35 am | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 15/05/2024 01:35 am | NUVATION BIO INC.: Q1 2024 Earnings Release |
| 14/05/2024 05:00 pm | ABSCI CORPORATION: Q1 2024 Earnings Release |
| 14/05/2024 11:20 am | BELITE BIO, INC: Q1 2024 Earnings Release |
| 14/05/2024 | POLARIS GROUP: Q1 2024 Earnings Release |
| 14/05/2024 02:00 am | AEROVATE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 13/05/2024 04:30 pm | APOGEE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 13/05/2024 04:30 am | PRAXIS PRECISION MEDICINES, INC.: Q1 2024 Earnings Release |
